Basic Information
OPKO Biologics is a clinical-stage company developing next-generation, longer-lasting therapeutic protein and peptide drug candidates using CTP, reversible PEGylation, and stabilizer-based technologies.
OPKO Biologics
Israel
51~100 people
January 11, 2001
contact_opkobiologics@opko.com
Enterprise Profile
Industrial Sector
Concept
Application Scenarios